- Home
- LXEH vs ANVS Comparison
LXEH vs ANVS Comparison
Compare LXEH & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LXEH
- ANVS
- Stock Information
- Founded
- LXEH 2001
- ANVS 2008
- Country
- LXEH China
- ANVS United States
- Employees
- LXEH N/A
- ANVS N/A
- Industry
- LXEH Other Consumer Services
- ANVS Biotechnology: Pharmaceutical Preparations
- Sector
- LXEH Real Estate
- ANVS Health Care
- Exchange
- LXEH Nasdaq
- ANVS Nasdaq
- Market Cap
- LXEH 55.2M
- ANVS 48.3M
- IPO Year
- LXEH 2020
- ANVS 2020
- Fundamental
- Price
- LXEH $0.82
- ANVS $2.26
- Analyst Decision
- LXEH
- ANVS Strong Buy
- Analyst Count
- LXEH 0
- ANVS 4
- Target Price
- LXEH N/A
- ANVS $17.33
- AVG Volume (30 Days)
- LXEH 4.6M
- ANVS 216.3K
- Earning Date
- LXEH 09-26-2025
- ANVS 11-07-2025
- Dividend Yield
- LXEH N/A
- ANVS N/A
- EPS Growth
- LXEH N/A
- ANVS N/A
- EPS
- LXEH N/A
- ANVS N/A
- Revenue
- LXEH $4,493,795.00
- ANVS N/A
- Revenue This Year
- LXEH N/A
- ANVS N/A
- Revenue Next Year
- LXEH N/A
- ANVS N/A
- P/E Ratio
- LXEH N/A
- ANVS N/A
- Revenue Growth
- LXEH N/A
- ANVS N/A
- 52 Week Low
- LXEH $0.51
- ANVS $1.11
- 52 Week High
- LXEH $50.08
- ANVS $10.54
- Technical
- Relative Strength Index (RSI)
- LXEH 25.18
- ANVS 50.16
- Support Level
- LXEH $0.51
- ANVS $1.88
- Resistance Level
- LXEH $3.28
- ANVS $2.51
- Average True Range (ATR)
- LXEH 0.41
- ANVS 0.11
- MACD
- LXEH -0.25
- ANVS 0.02
- Stochastic Oscillator
- LXEH 11.40
- ANVS 78.08
About LXEH Lixiang Education Holding Co. Ltd.
Lixiang Education Holding Co Ltd is a private primary and secondary education service provider in Lishui City, Zhejiang Province. Its private education services primarily include primary and middle school education from grade 1 to grade 9. The company also offers high school education services at its High School Divisions.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.